| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1600bd7a2bd0638198d6e1a3b8e09b91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4f405b09418d03164df8f1817f49cda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2325e291ffd61a2c34633357154def32 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate |
1991-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9c9a69375684a4c56a360b0eb13345e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c98e06c5d5dee935f27050ee9848765b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d743b11f54898961ba9ae94bd61a3ce |
| publicationDate |
1993-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0563244-A1 |
| titleOfInvention |
Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
| abstract |
Methods for detecting elevated levels of the phospholipase A2 activation protein in people who are believed to have rheumatoid arthritis for the purpose of indicating rheumatoid arthritis in the person include the steps of following: use of a fluid or tissue sample from said person's body; contacting the sample with a specific antibody against the phospholipase A2 activating protein so that the antibody binds to the phospholipase A2 activating protein in the sample; detection of the antibody thus indicating the presence of the phospholipase A2 activating protein so that high levels of phospholipase A2 activating protein in the sample compared to levels found in people not suffering from rheumatoid arthritis indicates the presence of rheumatoid arthritis in the person in question. Rheumatoid arthritis detection kits and reagents are also described. |
| priorityDate |
1990-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |